Status:

RECRUITING

Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application

Lead Sponsor:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Conditions:

Retinal Diseases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The MRI perfusion imaging using arterial spin labeling (ASL)'s non-invasive technique (i.e. without injection of contrast medium) allows, thanks to recent technological improvement of the spatial reso...

Eligibility Criteria

Inclusion criteria:

  • Carrier of target pathologies: TAO optic neuropathy, inflammatory optic neuropathy, ischemic optic neuropathy.
  • no cardiovascular risk factors or other ophthalmological pathology
  • adhere to the study protocol after reading the patient information document
  • signe the informed consent form to participate in the study
  • do not have any contraindications to an MRI examination

Exclusion criteria

  • Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…)
  • Severe claustrophobia

Key Trial Info

Start Date :

January 10 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05724641

Start Date

January 10 2023

End Date

June 30 2026

Last Update

May 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cliniques Universitaires Saint Luc

Brussels, Brussels Capital, Belgium, 1200

Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application | DecenTrialz